Skip to search formSkip to main contentSkip to account menu

GT 2331

Known as: GT-2331 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
GT-2331 [(+)-1] is one of the most potent members of a class of chiral drug substances used to regulate the synthesis and release… 
2005
2005
Previously reported pharmacological studies using the imidazole-containing histamine H3 receptor ligands GT-2331 (Cipralisant… 
2004
2004
GT-2331 is a potent histamine H(3) antagonist which has entered clinical trials. Efficient multigram syntheses of this compound… 
2002
2002
2000
2000
The histamine H3 receptor provides a negative feedback mechanism for the release and synthesis of histamine. On non-histaminergic… 
1999
1999
Previously, a novel series of 1H-4-substituted imidazole compounds were described as potent and selective histamine (HA) H3…